Ameriprise’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Ameriprise’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-40,971	Closed	-$1.21M	–	3955
2015 Q4	$1.21M	Buy	40,971 +446	+1%	+$13.5K	﹤0.01%	2869
2015 Q3	$1.28M	Buy	40,525 +7,145	+21%	+$342K	﹤0.01%	2870
2015 Q2	$1.98M	Buy	33,380 +30,364	+1,007%	+$2.14M	﹤0.01%	2767
2015 Q1	$322K	Sell	3,016 -14,349	-83%	-$1.37M	﹤0.01%	3387
2014 Q4	$1.63M	Buy	17,365 +17,355	+173,550%	+$1.66M	﹤0.01%	2644
2014 Q3	$1K	Hold	10	–	–	﹤0.01%	5659
2014 Q2	$1K	Buy	10 +9	+900%	+$552	﹤0.01%	5451
2014 Q1	$0	Buy	+1	New	+$33	﹤0.01%	5475
2013 Q4	–	Sell	-109	Closed	-$3K	–	5627
2013 Q3	$3K	Sell	109 -500	-82%	-$16.1K	﹤0.01%	5359
2013 Q2	$22K	Buy	+609	New	+$22.8K	﹤0.01%	4221

Other funds holding PTX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise's PTX Position: Q1 2016 in Review

Ameriprise sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2016, closing a stake of 40,971 shares — an estimated $1.21M sold.

Ameriprise first reported a position in PTX in Q2 2013 and held it in 10 quarters. The position peaked at $1.98M in Q2 2015. 88 funds tracked by Wall St. Rank hold PTX as of Q1 2016.

Ameriprise reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2016 after selling out during the quarter.
Ameriprise sold 40,971 Pernix Therapeutics Holdings, Inc. shares in Q1 2016, an estimated $1.21M.
Ameriprise first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 10 quarters.
Ameriprise's Pernix Therapeutics Holdings, Inc. position peaked at $1.98M in Q2 2015.
88 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2016.

Based on Ameriprise's 13F filing for Q1 2016, filed 12 May 2016.